EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 20-Oct-2026 17:17 ET (20-Oct-2026 21:17 GMT/UTC)

Cancer prevention and screening takes center stage during DCSummit convened by NCCN

National Comprehensive Cancer Network
Meeting Announcement

The National Comprehensive Cancer Network^® (NCCN^®) hosted a two-day summit focused on expanding access to life-saving cancer prevention and screening. The event examined policy solutions at both the population and individual levels, with particular attention to equity, innovation, and access.

NIH honors Sylvester scientist developing cancer therapy that can evolve to outsmart tumors

University of Miami Miller School of Medicine
Grant and Award Announcement

Leor Weinberger, Ph.D., virologist and professor with Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, has been awarded the National Institutes of Health (NIH) most prestigious award—the NIH Director’s Pioneer Award—for his “High-Risk, High-Reward Research” to develop a novel cancer therapy with the ability to mutate, or evolve, over time.

Making pediatric cancer more ‘visible’ boosts immunotherapy response

Penn State
Peer-Reviewed Publication

A new preclinical study from researchers at Penn State College of Medicine revealed blocking a specific protein makes pediatric cancer cells easier to detect and more vulnerable to treatment, potentially boosting effectiveness of cancer immunotherapy.

Journal: Autophagy
Funder: Four Diamonds, Lois High Berstler Research Endowment

Dr. Dennis Slamon awarded the 2026 Albany Prize for developing lifesaving cancer treatments

University of California - Los Angeles Health Sciences
Grant and Award Announcement

Dr. Dennis Slamon, a pioneering oncologist and researcher at the UCLA Health Jonsson Comprehensive Cancer Center, has been awarded the 2026 Albany Prize for discoveries that transformed the understanding and treatment of cancer.

Newly identified prostate cell type may help explain why enlarged prostate develops in one region of gland

Johns Hopkins Medicine
Peer-Reviewed Publication

Researchers at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center have identified a distinct type of prostate cell that may help solve the long-standing mystery of why benign prostatic hyperplasia (BPH) — a noncancerous enlargement of the prostate that commonly affects men as they age — develops almost exclusively in one region of the prostate.

Journal: The Journal of Pathology
Funder: Prostate Cancer Foundation, the Allegheny Health Network Johns Hopkins Pilot Project, the Patrick G. Walsh Fund, the Irving Hansen Foundation, Commonwealth Foundation, the Maryland Cigarette Restitution Fund

Mini-GRID radiotherapy reduces senescence while preserving growth inhibition in glioma cells

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY — October 6, 2026 — A new research paper was recently published in Volume 18 of Aging, titled “Spatially fractionated mini-GRID radiotherapy differentially modulates radiation-induced senescence in murine glioma and normal cells.”

Journal: Aging-US

Dr. Olivier Elemento wins NIH Director’s Pioneer Award

Weill Cornell Medicine
Grant and Award Announcement

Dr. Olivier Elemento, the director of the Englander Institute for Precision Medicine at Weill Cornell Medicine, has been awarded an NIH Director's Pioneer Award to build an artificial intelligence (AI) tool to accelerate cancer research, starting with lung cancer.

Texas Children’s Dr. Michael Taylor honored by CPRIT for advancing childhood brain tumor research

Texas Children's Hospital
Grant and Award Announcement

Dr. Michael Taylor, a Texas Children’s pediatric neurosurgeon and researcher whose work has advanced understanding of childhood brain tumors, is among the first four grantees to receive a Texans Conquer Cancer Award from the Cancer Prevention and Research Institute of Texas (CPRIT).

How does early gastric cancer arise? The key role of the spatial niche

Chinese Medical Journals Publishing House Co., Ltd.
Peer-Reviewed Publication

This study shows that early gastric cancer arises within an inflammation-associated spatial niche and identifies the SOX9-CXCL axis as a targetable mechanism.

Journal: Chinese Medical Journal
Funder: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Taishan Scholars Program of Shandong Province, Outstanding Young and Middle-aged Scholar of Shandong University, Shandong University Interdisciplinary Cultivation Program

Cancer trial drug may work differently than scientists believed, raising concerns for clinical research

University of Sydney
Peer-Reviewed Publication

A cancer drug currently being tested in patients may have entered clinical trials based on an incorrect understanding of how it works, according to a new study led by the University of Sydney in collaboration with Goethe University, Oxford University and the Institute of Cancer Research, London.

Journal: Nature Chemical Biology
Funder: National Health and Medical Research Council, Tour de Cure, Tim Trigg Scholarship into Glioblastoma Research

14
15
16
17
18